Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom

Fig. 2

Clinical Outcomes. Kaplan-Meier Plots of a overall survival (OS) in the overall population, b OS by first-line (1 L) drug class, c time to treatment discontinuation (TTD) in the overall population, d TTD by 1 L drug class, e time to next therapy (TtNT) in the overall population, and f TtNT by drug class. Dashed lines denote median values. IO, immuno-oncology

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us